Foghorn Therapeutics Inc. (FHTX) Tops Q1 EPS by 3c

Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.59), $0.03 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.86 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• BofA maintains underperform ratings on six BDC stocks